SCN2A ENCEPHALOPATHY

Clinical trials for SCN2A ENCEPHALOPATHY explained in plain language.

Never miss a new study

Get alerted when new SCN2A ENCEPHALOPATHY trials appear

Sign up with your email to follow new studies for SCN2A ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for kids with devastating seizure disorder

Disease control Recruiting now

This study is testing whether a new drug called elsunersen can safely reduce seizures in young children with a rare and severe form of genetic epilepsy (SCN2A-DEE). It will involve about 50 children who started having seizures before 3 months old. Some children will receive the r…

Matched conditions: SCN2A ENCEPHALOPATHY

Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

SCN2A ENCEPHALOPATHY

Get alerted when new SCN2A ENCEPHALOPATHY trials appear

New hope for kids with devastating seizure disorder